What's New in AML: Approach to Relapsed and Refractory Disease
By
Dana-Farber Cancer Institute
FEATURING
Marlise R. Luskin
By
Dana-Farber Cancer Institute
FEATURING
Marlise R. Luskin
Login to view comments.
Click here to Login